MLAB Hematology Fall 2007 Keri Brophy-Martinez

Slides:



Advertisements
Similar presentations
Myeloma Round Table Beth Faiman MSN, APRN-BC, AOCN Nurse Practitioner, Cleveland Clinic Pre-Doctoral Fellow, Case Western Reserve.
Advertisements

Serum Electrophoresis AND IMMUNOFIXATION june 2013 Dr. Nitin A Inamdar Department of Biochemistry Tata Memorial Center
Tabuk University 1 3 rd Year – Level 5 – AY Faculty of Applied Medical Sciences Department Of Medical Lab. Technology.
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Staff Oncologist, Mayo Clinic Arizona
Chapter 21 Monoclonal Gammopathies
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications.
CLS 404 Immunology Protein Abnormalities
Diagnosis of Paraprotein Diseases CLS 404 Immunology Protein Abnormalities.
Waldenström’s Macroglobulinemia And the Hyperviscosity Syndromes.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Educational Presentation. Program Overview Provide information on The Leukemia & Lymphoma Society Describe blood cancers Explain Pennies for Patients.
Chronic lymphocytic leukemia (1)
Waldenstrom’s Macroglobulinemia
Terry Kotrla, MS, MT(ASCP)BB Topic 3 Autoimmunity Part 8 Immunoproliferative Diseases.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Multiple Myeloma Alan Johns, M.D. Kristine Krafts, M.D.
Understanding Your Blood Work
Director of Scientific Affairs
Multiple Myeloma Definition:
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
IMMUNOCHEMISTRY PROFILES Dr. Thomas Williams. TESTS DISEASES CASES.
Multiple Myeloma Definition:
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Awareness Is Everything By Karis M. Blalock. Hypothesis Why is it important to understand what Multiple Myeloma is?
Epidemiology 12,000 deaths in United States per year
CASE 5 56 yr-old man HIV Asymptomatic CD4 840 HIV viral load
LYMPHOPROLIFERATIVE DISORDERS
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
MLAB 1415: H EMATOLOGY K ERI B ROPHY -M ARTINEZ Chapter 26: Lymphoid Malignancies Part Two.
Biological functions transport –albumin –transferin –ceruloplasmin –haptoglobin oncotic pressure regulation coagulation immunity.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Jesse C James MD AM Report May 7,  Proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein  Malignant.
Chicago Medical School
Myeloproliferative Lymphoproliferative & Immunoproliferative disorders.
 Serum protein electrophoresis is an easy method of separating serum proteins based on their net charge, size, and shape.  A small amount of serum is.
Plasma cell Dyscrasia 1- B.M.G. 2- Multiple Myeloma 3- Waldenstrom Macroglubolenemia 4- Heavy Chain disease 5- Amyloidosis.
Serum Protein Electrophoresis (SPEP)
M. Multiple Myeloma Malignant proliferation of plasma cells. Malignant proliferation of plasma cells. Normal plasma cell form Ig which contain heavy and.
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
Para-proteinaemias Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor 7 th march 2016.
M protein detection and characterization
Case Study Multiple Myeloma.
Miten R. Patel, MD Cancer Specialists of North Florida
Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor
Paraproteinaemias. Multiple myeloma. Amyloidosis. Part 2 Dr
Prepared by : IBRAHEEM NIDAL ABU ATWAN SAEED YEHYA HAMMODA
Chapter 13 Lesson 13.2 anemia Aplastic anemia Hemolytic anemia Pernicious anemia sickle cell thalassemia Hemochromatosis polycythemia vera Hemophilia purpura.
Fig-2: Sample in Red topped clot activator tubes
MULTIPLE MYELOMA (MM) objective: definition of MM Biochemical investigation in Diagnosis.
MLAB Hematology Keri Brophy-Martinez
MLAB 1415-Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
Section III Physiological Biochemistry Universities Press
A young patient with multiple myeloma
Multiple myeloma (MM) & related disorders
Hyperviscosity syndrome
Myeloma: Symptoms to diagnosis Can we do better?
PARAPRTEINAEMIA and MULTIPLE MYELOMA
Multiple myeloma NOTE: Want a different image on this slide? Select the picture and delete it. Now click the Pictures icon in the placeholder to insert.
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk.
Bence Jones protein The Bence Jones protein was described by the English physician Henry Bence Jones in 1847 and published in 1848.Henry Bence Jones The.
Presentation transcript:

MLAB 1315- Hematology Fall 2007 Keri Brophy-Martinez Unit 24: MULTIPLE MYELOMA AND RELATED PLASMA CELL DISORDERS

Multiple myeloma This is a disorder in which there is overproduction of abnormal plasma cells which are the final stage in the development of B lymphocytes.

Multiple myeloma Etiology 5 cases per 100,000 persons per year 50% greater risk for men than women Risk increases with age; rare under 40 Suspected cause is chronic stimulation of the immune system from environmental sources.

Multiple myeloma Characteristics Expanding plasma cell mass in bone marrow causes pancytopenia and destruction of the bone cortex. This is painful because nerves get stretched. Increased production of immunoglobulin heavy and light chains (monoclonal gammopathy) Heavy chains: IgG, IgA, IgD, IgE, IgM Light chains: kappa, lambda Most common type of multiple myeloma is increased production of IgG. Hyperviscosity syndrome Excess immunoglobulin causes viscous blood which sludges and causes fluid congestion. Bence-Jones protein Light chains spill into the urine and can be detected by lab test. Causes kidney damage

Multiple myeloma Laboratory tests Protein electrophoresis - separates the proteins in the serum Immunoelectrophoresis - identifies the heavy and light chains Quantitative immunoglobulins - quantitative measurement of the immunoglobulin chains CBC and peripheral smear Red cells form characteristic rouleaux formation (resemble stacked coins) Plasma cells may be seen in advanced cases The presence of significant numbers of plasma cells on peripheral blood smear constitutes plasma cell leukemia

Multiple myeloma: Lab tests con’t ESR Increased - serum protein causes red cells to stick together and fall faster Bone marrow Increased number of plasma cells which form “sheets” Chemistry studies Increased BUN and creatinine (kidney tests) Increased calcium Increased LDH

Multiple myeloma Treatment Chemotherapy Radiation for localized areas Bone marrow transplant for younger patients

Waldenström’s macroglobulinemia Overproduction of monoclonal IgM

Waldenström’s macroglobulinemia Clinical features Usually presents when patients are in their 70's. Hyperviscosity syndrome is common. Blurred vision IgM interferes with platelet function and bleeding problems occur. Characteristic bruising is called cryoglobulinemic purpura Cryoglobulins precipitate on exposure to cold

Waldenström’s macroglobulinemia Therapy Chemotherapy Plasmapheresis